Z. Pi

发表

Identification of Reversible Small Molecule Inhibitors of Endothelial Lipase (EL) which Demonstrate HDL-C Increase In Vivo.

David S. Taylor, K. Behnia, E. Liu, 2020, Journal of medicinal chemistry.

Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors.

R. Parker, L. Hamann, M. Kirby, 2007, Bioorganic & medicinal chemistry letters.

Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.

Steven A. Spronk, P. Lam, D. Schnur, 2013, Journal of medicinal chemistry.

2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agents.

P. Lam, R. Rehfuss, Christine S. Huang, 2013, Bioorganic & medicinal chemistry letters.

Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold.

D. Cheney, S. Sheriff, E. Liu, 2013, Bioorganic & medicinal chemistry letters.

Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.

A. Mathur, G. Bisacchi, W. Meng, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.

G. Bisacchi, W. Meng, R. Zahler, 2002, Bioorganic & medicinal chemistry letters.

Synthesis of potent and highly selective inhibitors of human tryptase.

G. Bisacchi, W. Meng, R. Zahler, 2002, Bioorganic & medicinal chemistry letters.

Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase.

David S. Taylor, Brandon L. Parkhurst, E. Liu, 2019, Bioorganic & medicinal chemistry letters.

Sulfonylated Benzothiazoles as Inhibitors of Endothelial Lipase.

David S. Taylor, Michael A. Galella, L. Abell, 2018, ACS medicinal chemistry letters.

Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.

Haixia Wang, Stanley R Krystek, Jacek Ostrowski, 2007, Journal of medicinal chemistry.

Identification of 6-Hydroxypyrimidin-4(1H)-one-3-carboxamides as Potent and Orally Active APJ Receptor Agonists.

P. Gargalovic, D. Gordon, R. Wexler, 2021, ACS medicinal chemistry letters.

Identification of a Hydroxypyrimidinone Compound (21) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure.

P. Gargalovic, R. Wexler, Tao Wang, 2021, Journal of medicinal chemistry.